A therapy for the focal treatment of early-stage prostate cancer.

PositionHEALTH BEAT - Brief article

A therapy for the focal treatment of early-stage prostate cancer has been approved by Cofepris, Mexico's health authority. The therapy--created at the Weizmann Institute of Science, Rehovot, Israel--involves a laser and a novel drug, TOOKAD Soluble. Successful Phase III clinical trials in Europe and Latin America (Mexico, Peru, and Panama) confirmed the high rate of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT